Blend Labs, Inc. BLND
1.11
0.04
3.74%
as of 25 Sep
- Market cap
- $253.1M
- P/E
- 0.0×
Follow BLND
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
7.80 | 6.37 | 3.41 | 3.16 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 54.31 | |
P/Operating CF |
(307.48) | 803.27 | 59.11 | 51.75 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
8.31 | 6.93 | 4.03 | 3.88 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
169.74 | 74.38 | (410.85) | 38.27 | |
EV/FCF |
(141.27) | (10,571.10) | (53.31) | 66.75 | |
Quick Ratio |
1.96 | 1.99 | 1.50 | 1.27 | |
Current Ratio |
2.54 | 2.53 | 1.81 | 1.62 | |
Net Debt/EBITDA |
23.48 | 31.93 | 18.89 | (131.19) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.65 | 0.71 | 0.73 | 0.79 | |
Operating CF/Net income |
(0.39) | (0.13) | (0.58) | (1.24) | |
Capex/Depreciation |
(1.65) | (0.55) | (0.58) | (0.43) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
25.93% | 27.88% | 30.52% | 25.66% | |
Selling, General and Administrative Expense of Revenue |
63.15% | 60.00% | 59.50% | 52.53% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
23.43% | 23.50% | 21.98% | 20.62% | |
Graham Net Nets |
(0.09) | (0.13) | (0.29) | (0.35) | |
Graham Number |
0.31 | 0.49 | 0.67 | 0.75 | |
Earnings Yield |
(2.47%) | (2.96%) | (5.29%) | (4.68%) | |
Free Cash Flow Yield |
(0.75%) | (0.01%) | (2.22%) | 1.84% | |
Revenue per Share |
0.13 | 0.12 | 0.12 | 0.14 | |
Operating CF per Share |
(0.01) | 0.00 | 0.03 | 0.03 | |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.02) | 0.00 | 0.02 | 0.03 | |
Cash per Share |
0.30 | 0.27 | 0.23 | 0.19 | |
Shareholders Equity per Share |
(0.05) | (0.12) | (0.22) | (0.31) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.05) | (0.12) | (0.22) | (0.31) | |
Free Cash Flow |
(5.76) | (0.02) | 6.24 | 7.10 | |
Working Capital |
70.32 | 60.35 | 41.65 | 29.18 | |
Capital Expenditures |
(2.68) | (1.00) | (1.12) | (0.82) | |
Net Current Asset Value |
(86.06) | (100.72) | (124.07) | (142.05) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.08 | 0.03 | 0.04 | 0.02 | |
Net Profit Margin |
24.27% | (23.77%) | (41.44%) | (18.94%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
14.05 | 11.72 | 14.29 | 14.69 | |
Average Payables |
1.32 | 1.74 | 1.46 | 0.81 | |
Average Assets |
187.85 | 174.07 | 174.76 | 163.32 | |
Average Common Equity |
(31.04) | (43.41) | (36.40) | (48.47) |
Columns are period end dates